Projected Earnings Date: 2023-11-26    (Delayed quote data   )
Last
 
Change
 ⇓ 0.00   (%)
Volume
  0
Open
 
High
 
Low
 
8EMA (Daily)
 0.00
40EMA (Daily)
 
50EMA (Daily)
 
STO (Daily)
 
MACD Hist (Daily)
 
8EMA (Weekly)
 1.306
40EMA (Weekly)
 2.44
50EMA (Weekly)
 2.99
STO (Weekly)
 3.655
MACD Hist (Weekly)
 -0.264
Lannett Co Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products. It offers solid oral, extended-release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. In addition, the company also provides its products for various medical indications comprising glaucoma, gastrointestinal, migraine, obesity, respiratory, and others. It operates in the segment of generic pharmaceuticals. Its customers include generic pharmaceutical distributors, drug wholesalers, chain drug stores, private label distributors, mail-order pharmacies, and others.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com